.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)
NCT05389007 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 156
Last updated 2022-05-24
Summary
Open, multi-center, observational, prospective cohort study, only disease-indicated treatment, in patients with clinically diagnosed acquired and congenital TTP regardless of gender, ethnicity, and comorbidities, over the age of 18 for 1.) prospective investigation of patients with TTP in an acute bout and during long-term follow and 2.) assessment of prevalence, course of disease, success of therapy, possible triggers for relapses and possibilities for better diagnosis and prognosis.
Conditions
- Thrombotic Thrombocytopenic Purpura
Sponsors & Collaborators
-
Johannes Gutenberg University Mainz
lead OTHER
Principal Investigators
-
Charis v. Auer-Wegener · Universitätsmedizin Mainz
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-08
- Primary Completion
- 2025-07-01
Countries
- Germany
Study Locations
More Related Trials
-
The United Kingdom Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry)
NCT03832881 ·Status: UNKNOWN
-
Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
NCT00251277 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
Construction of a Database for TTP
NCT05571774 ·Status: RECRUITING
-
Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
NCT00907751 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
NCT00937131 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
NCT00828750 ·Status: COMPLETED ·Phase: PHASE3
-
Italian iTTP Registry
NCT06376786 ·Status: RECRUITING
-
Investigation on a Dynamic Cohort of Italian Patients With Active ITP
NCT03465020 ·Status: UNKNOWN
-
ITP Registry and Accompanying Biospecimen Collection
NCT05152238 ·Status: RECRUITING
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Aspirin for Prophylaxis of TTP
NCT05568147 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura
NCT00162006 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308 ·Status: COMPLETED
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)
NCT06945861 ·Status: RECRUITING
-
Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center
NCT07205861 ·Status: RECRUITING
-
Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy
NCT00225875 ·Status: TERMINATED ·Phase: PHASE2
-
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
NCT00005570 ·Status: COMPLETED
-
Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP]
NCT03519672 ·Status: COMPLETED
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP
NCT04985318 ·Status: ACTIVE_NOT_RECRUITING
-
Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?
NCT04128358 ·Status: UNKNOWN ·Phase: NA
-
Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10
NCT00168038 ·Status: COMPLETED ·Phase: PHASE3
-
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
NCT01257269 ·Status: RECRUITING